EC-industry project aims to develop non-animal methods for repeated dose toxicity testing
March 03, 2011 | Featured,News | admin | 
Print This Post
Print This Post
1-3 March marked the official kick-off of the €50 million European Commission-COLIPA ‘Safety Evaluation Ultimately Replacing Animal Testing’ (SEURAT) programme aimed at replacement of current repeated dose systemic toxicity testing in human safety assessment. The meeting brought together the coordinators of the seven new large-scale and projects, as well as the leaders of ongoing projects funded under the health theme of the 6th and 7th EU Research Framework Programmes.
Latest News & Events
-
New AXLR8 Report: Alternative Testing Strategies – Progress Report 2011
The EU FP7-funded co-ordination project AXLR8 has announced the availability of the publication Alternative Testing Strategies: Progress Report 2011 & ... -
Final START-UP report now available
The final report of the FP7-funded support action START-UP (Scientific and Technological Issues in 3Rs Alternatives Research in The Process ... -
US FDA accepts cell-based potency test for Botox
California-based Allergan, Inc. has had its in-vitro, cell-based assay for testing the stability and potency of Botox and Botox cosmetic, ... -
ECHA releases report on use of non-animal methods & testing strategies under REACH
The European Chemicals Agency has published two major reports on the working of REACH and CLP Regulations and on the ...
